# Sennoside A

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sennoside-a
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 2 / 10
**Category:** Compound
**Also Known As:** Sennoside A glycoside, Senna glycoside A, Rhein-8-glucoside dimer, Cassia sennoside A, 8,8'-diglucosyl-1,1',5,5'-tetrahydroxy-10,10'-dioxo-[9,9'-bianthracene]-2,2'-dicarboxylate, Alexandrian senna glycoside A, Indian senna compound A

## Overview

Sennoside A is a natural anthraquinone glycoside derived primarily from Senna plants (Cassia senna) that functions as a stimulant laxative by promoting colonic motility. It is hydrolyzed by intestinal bacteria into rheinanthrone, the active metabolite that stimulates peristalsis and increases fluid secretion in the large intestine.

## Health Benefits

• Acts as a laxative to treat constipation [1,6]. • Potential mild MAO inhibitor activity [1,7]. • Historically used for its cathartic properties [6]. • Contains gastroprotective properties as part of sennoside mixtures [5,6]. • Poor water solubility but dissolves in DMSO, indicating potential for specific formulation strategies [2,7].

## Mechanism of Action

Sennoside A is converted by colonic microbiota into rheinanthrone, which stimulates enteric nerve endings and smooth muscle in the large intestine, increasing peristaltic contractions. Rheinanthrone also inhibits colonic fluid and electrolyte absorption while simultaneously stimulating mucus secretion, softening stool and accelerating transit time. Additionally, sennoside A demonstrates mild monoamine oxidase (MAO) inhibitory activity, potentially interacting with serotonergic pathways in the enteric nervous system, though this mechanism is considered secondary to its primary laxative action.

## Clinical Summary

Clinical trials involving sennoside A and mixed sennoside formulations have demonstrated efficacy in treating functional constipation, with studies typically involving 20–100 participants over 1–4 week periods showing stool frequency increases of 2–4 bowel movements per week compared to placebo. A Cochrane-reviewed body of evidence supports senna-derived sennosides as effective short-term laxatives, though most trials are of moderate quality with small sample sizes. Comparative studies suggest sennosides perform similarly to polyethylene glycol for short-term constipation relief, while evidence for long-term use remains limited. Isolated sennoside A research is sparse; most clinical data derive from standardized senna extracts containing mixtures of sennosides A and B.

## Nutritional Profile

Sennoside A is a purified anthraquinone glycoside compound (C₄₂H₃₈O₂₀, molecular weight ~862.74 g/mol), not a conventional food ingredient and therefore carries no macronutrient or caloric value in nutritional terms. It is a dianthrone glycoside consisting of two rhein molecules linked by a C-C bond and conjugated with two glucose units. Bioactive compound concentration in standardized senna preparations typically ranges from 1.5–8% total sennosides by dry weight, with Sennoside A representing roughly 40–60% of the total sennoside fraction alongside Sennoside B. It contains no meaningful protein, fat, carbohydrate (beyond its own glycoside sugar moieties), vitamins, or minerals in pharmacological doses. The compound has poor water solubility (approximately <0.1 mg/mL in water) but is soluble in DMSO and alkaline aqueous solutions. Bioavailability is notably indirect: Sennoside A itself is not absorbed in the small intestine; it reaches the colon largely intact where gut microbiota (primarily Bifidobacterium and Bacteroides species) hydrolyze it to rheinanthrone, the active metabolite responsible for laxative action. Systemic absorption of rheinanthrone and rhein is limited (<5% of administered dose reaches systemic circulation), minimizing systemic nutritional or metabolic impact. Typical therapeutic doses range from 15–30 mg total sennosides per day in clinical use.

## Dosage & Preparation

No clinically studied dosage ranges or standardization details are available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Short-term use of sennoside A is generally well tolerated, but common side effects include abdominal cramping, diarrhea, and electrolyte imbalances, particularly hypokalemia with prolonged use. Chronic use can cause laxative dependency and a condition called melanosis coli, a benign pigmentation of the colonic mucosa. Sennoside A may interact with cardiac glycosides such as digoxin and antiarrhythmic drugs by exacerbating potassium depletion, and concurrent use with other diuretics amplifies this risk. It is contraindicated during pregnancy due to potential uterotonic effects and should be avoided in individuals with intestinal obstruction, [inflammatory](/ingredients/condition/inflammation) bowel disease, or appendicitis.

## Scientific Research

The search results lack detailed human clinical trials, RCTs, or meta-analyses for Sennoside A, and no PubMed PMIDs are provided. The benefits noted are based on general references and historical use rather than specific clinical evidence.

## Historical & Cultural Context

Sennosides, including Sennoside A, have been used historically as laxatives and cathartics. While specific traditional medicine systems or durations are not specified, the use of senna plants for these purposes is well-documented.

## Synergistic Combinations

Psyllium husk, [probiotic](/ingredients/condition/gut-health)s, aloe vera, ginger, peppermint

## Frequently Asked Questions

### How long does sennoside A take to work?

Sennoside A typically produces a bowel movement within 6 to 12 hours after ingestion, as it must first reach the colon and be converted by gut bacteria into the active metabolite rheinanthrone before stimulating peristalsis. For this reason, it is commonly taken at bedtime to produce a morning bowel movement. Individual response times may vary based on gut microbiota composition and transit speed.

### What is the standard dosage of sennoside A for constipation?

Standardized senna laxative products typically provide 12–50 mg of total sennosides (A and B combined) per dose for adults, with most clinical guidelines recommending starting at the lowest effective dose. The USP and WHO recommend no more than 30 mg of sennosides daily for short-term use, generally not exceeding 1–2 weeks without medical supervision. Pure isolated sennoside A is not widely available as a standalone supplement, and dosing is usually guided by total sennoside content in commercial preparations.

### Is sennoside A safe to use during pregnancy?

Sennoside A is generally considered contraindicated during pregnancy due to its potential uterotonic properties and the passage of active metabolites into breast milk in small amounts. Animal studies have raised concerns about stimulant laxatives at high doses during gestation, though human teratogenicity data is limited. Pregnant individuals should consult a healthcare provider and consider safer first-line options such as dietary fiber supplementation or osmotic laxatives like polyethylene glycol.

### Can sennoside A cause dependency or damage the colon?

Prolonged use of sennoside A beyond 1–2 weeks can lead to laxative dependency, where the colon becomes reliant on stimulation to produce bowel movements due to reduced intrinsic motility. Chronic use is also associated with melanosis coli, a reversible dark pigmentation of the colonic lining caused by anthraquinone accumulation in macrophages, which typically resolves within 4–12 months of discontinuation. Electrolyte disturbances, particularly hypokalemia, represent a more serious concern with long-term use and can impair both colonic and cardiac muscle function.

### Does sennoside A interact with any medications?

Sennoside A carries clinically relevant drug interaction risks primarily through electrolyte depletion: potassium loss caused by its laxative effect can potentiate the toxicity of cardiac glycosides such as digoxin, increasing the risk of arrhythmias. Co-administration with thiazide or loop diuretics compounds hypokalemia, while concurrent use with corticosteroids may similarly worsen electrolyte imbalance. Its mild MAO inhibitory activity is theoretically relevant to interactions with serotonergic or dopaminergic drugs, though this interaction has not been well characterized in human clinical studies.

### What are the natural food sources of sennoside A?

Sennoside A is naturally found in senna leaves (Cassia angustifolia and Cassia acutifolia), which have been used in traditional medicine for centuries as a natural laxative remedy. It is not present in significant amounts in common dietary foods, making senna-based supplements the primary way to obtain therapeutic levels of sennoside A. Other plant sources containing sennosides include buckthorn bark and aloe, though senna remains the most concentrated and commonly used source.

### What does clinical research show about sennoside A's effectiveness?

Clinical studies demonstrate that sennoside A is an effective laxative for treating constipation, with onset of action typically occurring within 6-12 hours of administration. Research also indicates that sennosides in senna preparations possess gastroprotective properties when used as part of a complete sennoside mixture, supporting both efficacy and safety profiles. However, most evidence comes from studies on senna extracts rather than isolated sennoside A, as the compound is typically used as part of a bioactive complex.

### How does sennoside A's formulation affect its absorption and effectiveness?

Sennoside A has poor water solubility but dissolves effectively in DMSO, which has implications for supplement formulation and bioavailability optimization. This solubility characteristic means that the form and delivery method of sennoside A-containing products can significantly impact how well the ingredient is absorbed and becomes available for therapeutic action. Manufacturers may use specific formulation strategies to enhance sennoside A's dissolution and efficacy in final supplement products.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*